Chalk up another victory for this company's most recent quarter
This company's new future is off to a good start, but what should you keep an eye out for?
With J&J's earnings out, what do you need to keep an eye on for the future?
Growth from the medical device company's smaller divisions offers hope that the firm can turn around its sales slump.
Abbott Laboratories' stock has enjoyed a good start to 2013. Will Q1 results help or hurt?
The robotic surgical device-maker faces some challenges to its da Vinci system.
The company continues moving forward without its proprietary pharmaceutical segment.
35 years of consecutive dividend increases, 20% annual growth potential in emerging markets, and a decade-long streak of annual revenue increases should put this company on Warren Buffett's radar.
A nonbinding Senate vote to repeal the medical-device tax shows the bipartisan support to repeal the levy.
$1 out of every $3 spent on health care is wasted. Can "talkative" medical devices help solve the problem?